论文部分内容阅读
1998年末我们应用低分子肝素钙治疗进展性脑梗塞,观察其疗效,并设对照分析,取得满意效果,现报告如下。 1 资料与方法 1.1 病例选择:所有病例均为首发病例,符合1995年10月全国第四届脑血管病学术会议制定的《各类脑血管病诊断要点》:并经头颅CT证实,且发病6小时后病情仍进行性加重者;脑干梗塞及复发脑梗塞者不入选,有应用低分子肝素钙等药物禁忌症如出血性疾病、消化性溃疡活动期等不入选,血压超
At the end of 1998, we applied low molecular weight heparin to treat progressive cerebral infarction, and observed its curative effect. We also made a comparative analysis and achieved satisfactory results. The report is as follows. 1 Materials and Methods 1.1 Case Selection: All cases were the first case, in line with the Fourth National Conference on cerebrovascular disease in October 1995 to develop “diagnostic points of various types of cerebrovascular disease”: and confirmed by head CT, and the incidence of 6 Hours later, the condition is still worsened; brainstem infarction and recurrent cerebral infarction were not selected, the application of low molecular weight heparin calcium and other drug contraindications such as hemorrhagic disease, peptic ulcer activity is not selected, blood pressure